PDX Portal

PDX INSIGHTS

PIONEERING CANCER RESEARCH

Breast Collection

Collection Summaries:

Collection Details:

Search All Columns:

			Patient Biomarkers at Diagnosis			PDX Biomarkers
Model IDFilter by Model ID	Patient IDFilter by Patient ID	Pathology Diagnosis	ERFilter by ER	PRFilter by PR	HER2Filter by HER2	ERFilter by ER	PRFilter by PR	HER2Filter by HER2	Germline BRCA1 StatusFilter by Germline BRCA1 Status	Germline BRCA2 StatusFilter by Germline BRCA2 Status	Path. Stage	Grade	Clinical Event Pt	Age at Diagnosis	Race	Treatment NaiveFilter by Treatment Naive	Patient TreatmentFilter by Patient Treatment
BCM-15006	13611+	Adenocarcinoma, metastatic, NOS (8140/6)	Negative	Negative	Negative	Negative	Negative	Negative	Wild Type	Wild Type		G3 (Poorly Differentiated)	Primary	33.91	White	No	Capecitabine,Carboplatin,Cisplatin,Cyclophosphamide,Doxorubicin,Eribulin,Paclitaxel
BCM-15171	5035+	Infiltrating ductular carcinoma (8521/3)	Negative	Negative	Positive	Negative	Negative	Positive	Wild Type	Wild Type	IV	G3 (Poorly Differentiated)	Distant Metastasis	30.18	White,Hispanic or Latino	No	Ado-Trastuzumab Emtansine,Capecitabine,Docetaxel,Fam-trastuzumab deruxtecan-nxki,Paclitaxel,Pertuzumab,Trastuzumab
HCI-001	Y0ACP5+	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IV		Primary	39.50	White	No	Adriamycin,Doxorubicin Liposomal,Paclitaxel
HCI-002	0RR2HE+	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	61.00	White	Yes	Zometa
HCI-003	3BW6YS	Infiltrating ductal carcinoma	Positive	Positive	Negative	Positive	Positive	Negative	Not Reported	Not Reported	IIIA	G3 (Poorly Differentiated)	Primary	52.00	White	Yes	Anastrazole,Carboplatin,Gemcitabine,Paclitaxel,Tamoxifen
HCI-004	N12K3Y	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IIA		Primary	54.83	Hispanic or Latino	Yes	Cytoxan,Docetaxel
HCI-005	79NTL6+	Mixed carcinoma	Positive	Positive	Positive	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	45.00	White	No	Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid
HCI-006	79NTL6+	Mixed carcinoma	Positive	Positive	Positive	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	45.00	White	No	Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid
HCI-007	79NTL6+	Mixed carcinoma	Positive	Positive	Positive	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	45.00	White	No	Aromasin,Capecitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fulvestrant,Gemcitabine,Letrozole,Liposomal Doxorubicin,Paclitaxel,Tamoxifen,Taxotere,Trastuzumab,Vinorebline,Zolendronic Acid
HCI-009	779812+	Adenocarcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IV	G3 (Poorly Differentiated)	Metastasis	42.00	White	No	5-Fluorouracil,Alternative Medicine,Anastrozole,Cyclophosphamide,Fulvestrant,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid
HCI-010	SUCWJ9+	Infiltrating ductal carcinoma	Negative	Negative	Negative	Negative	Negative	Negative	Not Reported	Not Reported	IV		Metastasis	47.00	White	No	Capcitabine,Cyclophosphamide,Doxetaxel,Doxorubicin,Liposomal Doxorubicin,Paclitaxel,Zolendronic Acid,supraclavicular nodes and axilla
HCI-011	Y0T0JD	Infiltrating ductal carcinoma	Positive	Positive	Negative	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	58.00	Hispanic or Latino	No	Arimidex,Capcitabine,Cyclophosphamide,Doxorubicin,Pacitaxel,chest wall and scar
HCI-012	2SF730	Infiltrating ductal carcinoma	Negative	Negative	Positive	Negative	Negative	Positive	Not Reported	Not Reported	IV		Metastasis	49.00	White	No	5-fluorouracil,Abraxane,Aldesleukin,Capecitabine,Capecitibine,Cyclophosphamide,Doxorubicin,Epirubicin,Herceptin,Interleukin 2,Lapatinab,Letrozole,Leucovarin,Methotrexate,Proleukin,Vinerolbine
HCI-013	B6WNCG+	Infiltrating lobular carcinoma	Positive	Positive	Negative	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	46.00	White	No	Abraxane,Aromasin,Capcitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fluorouracil,Gemcitabine,Letrozole,Leuprolide,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid
HCI-013EI	B6WNCG+	Infiltrating lobular carcinoma	Positive	Positive	Negative	Positive	Positive	Negative	Not Reported	Not Reported	IV		Metastasis	46.00	White	No	Abraxane,Aromasin,Capcitabine,Carboplatin,Cyclophosphamide,Doxorubicin,Fluorouracil,Gemcitabine,Letrozole,Leuprolide,Methotrexate,Paclitaxel,Tamoxifen,Zolendronic Acid

* indicates the model is private.
+ indicates the patient has multiple models.

SITE LINKS

Collections
Omics Tools
Publications
Our Team
Contact Us

COLLECTIONS

Bladder Breast Leukemia Liver Pancreas Sarcoma

CONTACT

PDX Development Unit
BCM PDX Core
PDX Pediatric Liver Program
Baylor College of Medicine

SUPPORTED BY

Cancer Prevention and Research
Institute of Texas (RP220646)

Dan L Duncan Cancer Center (P30 Cancer Center Support Grant NCI-CA125123)
Advanced Technology Core

© 2024 Biomedical Informatics Group, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine